ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Restoration of lipid homeostasis between TG and PE by the LXRα-ATGL/EPT1 axis ameliorates hepatosteatosis

Chen, Yulian; Jiang, Huanguo; Zhan, Zhikun; Lu, Jindi; Gu, Tanwei; Yu, Ping; Liang, Weimin; Zhang, Xi; Liu, Shuwen; Bi, Huichang; Zhong, Shilong*; Tang, Lan*广东省人民医院; 南方医科大学
Cell Death & Disease2023-2-6DOI: 10.1038/s41419-023-05613-6
4被引8阅读
引用收藏
分享

摘要

Converting lipid disturbances in response to energy oversupply into healthy lipid homeostasis is a promising therapy to alleviate hepatosteatosis. Our clinical studies found that a further elevation of triglyceride (TG) in obese patients with the body mass index (BMI) greater than 28 was accompanied by a further reduction of phosphatidylethanolamine (PE). Shorter survival and poor prognosis were shown for the patients with high TG and low PE levels. Liver X receptor alpha (LXR alpha) knockout mice aggravated high-fat diet (HFD)-induced obesity and lipid disorders, making the TG enrichment and the PE decrease more pronounced according to the liver lipidomics analysis. The RNA-seq from mice liver exhibited that these metabolism disorders were attributed to the decline of Atgl (encoding the TG metabolism enzyme ATGL) and Ept1 (encoding the PE synthesis enzyme EPT1) expression. Mechanistic studies uncovered that LXR alpha activated the ATGL and EPT1 gene via direct binding to a LXR response element (LXRE) in the promoter. Moreover, both the supplement of PE in statin or fibrate therapy, and the LXR alpha inducer (oridonin) ameliorated cellular lipid deposition and lipotoxicity. Altogether, restoration of lipid homeostasis of TG and PE via the LXR alpha-ATGL/EPT1 axis may be a potential approach for the management of hepatosteatosis and metabolic syndrome.

学科与关键词

关键词
LIVER-X-RECEPTORPPAR-ALPHAER STRESSMETABOLISMLXRPHOSPHATIDYLCHOLINEACCUMULATIONACTIVATIONDROPLETSHEALTH
相关
加载中…
  • Oridonin restores hepatic lipid homeostasis in an LXRa-ATGL/EPT1 axis-dependent manner
    Chen, Yulian; Jiang, Huanguo; Zhan, Zhikun; Lu, Jindi; Gu, Tanwei; Yu, Ping; Liang, Weimin; Zhang, Xi; Zhong, Shilong; Tang, Lan*Journal of Pharmaceutical Analysis, 2023, 13(11): 1281-1295.
  • Ascorbic acid inhibits transcriptional activities of LXRα to ameliorate lipid metabolism disorder
    Wang, Dandan; Yin, Zequn; Han, Lan; Zhang, Mengxue; Li, Huaxin; Yang, Xiaoxiao; Chen, Yuanli; Zhang, Shuang; Han, Jihong*; Duan, Yajun*Journal of Functional Foods, 2022, 88: 104901.被引 2
  • A new perspective on NAFLD: Focusing on the crosstalk between peroxisome proliferator-activated receptor alpha (PPARα) and farnesoid X receptor (FXR)
    Zhou, Shipeng; You, Huimin; Qiu, Shuting; Yu, Dawei; Bai, Yan; He, Jincan; Cao, Hua; Che, Qishi; Guo, Jiao*; Su, Zhengquan*Biomedicine and Pharmacotherapy, 2022, 154: 113577.被引 16
查看全部 →

发表信息

论文状态
公开发表
期刊
Cell Death & Disease
发表日期
2023-02-06
卷期
第 14 卷, 第 2 期
页码
85
DOI
10.1038/s41419-023-05613-6
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82274002, 81973388]; Marine Economy Development Project of Guangdong Province; Key Research and Development Program of Guangdong Province [2020B1111030005, S2021ZDZ042]; Science and Technology Innovation Project of Guangdong Medical Products Administration [GDNRC[2021]52]; [2019B020202002]

作者

  • C

    Chen, Yulian (第一作者)

    new · southern med univ

  • J

    Jiang, Huanguo

    new · southern med univ

查看全部 12 位作者收起作者
  • Z

    Zhan, Zhikun

    new · southern med univ

  • L

    Lu, Jindi

    new · southern med univ

  • G

    Gu, Tanwei

    new · southern med univ

  • Y

    Yu, Ping

    new · southern med univ

  • L

    Liang, Weimin

    new · southern med univ

  • Z

    Zhang, Xi

    new · southern med univ

  • L

    Liu, Shuwen

    new · southern med univ

  • B

    Bi, Huichang

    new · southern med univ

  • Z

    Zhong, Shilong (通讯)

    new · southern med univ · guangdong prov peoples hosp

  • T

    Tang, Lan (通讯)

    new · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417